Different Innate Immune Responses in BALB/c and C57BL/6 Strains following Corneal Transplantation.


Journal

Journal of innate immunity
ISSN: 1662-8128
Titre abrégé: J Innate Immun
Pays: Switzerland
ID NLM: 101469471

Informations de publication

Date de publication:
2021
Historique:
received: 09 03 2020
accepted: 25 06 2020
pubmed: 10 9 2020
medline: 12 11 2021
entrez: 9 9 2020
Statut: ppublish

Résumé

To investigate immunological differences and the role of CD38+/F4/80 + M1 macrophages in C57BL/6J- and BALB/c-recipient mouse corneal transplantation models. Allogeneic transplantation was performed crosswise in BALB/c mice and C57BL/6J mice; syngeneic transplantation was performed in both strains. Anterior chamber depth (ACD) was measured before and central corneal thickness (CCT) was measured both before and after transplantation. In vivo graft rejection was monitored using anterior eye segment optical coherence tomography (ASOCT) evaluating the CCT and grading of corneal oedema using a well-established clinical score (CS). Histology of corneal grafts was performed 18 or 21 days after surgery. Immunohistochemistry with anti-F4/80 antibody and anti-CD38 antibody was used for detecting M1 macrophages within the grafts. High CS and CCT values after allogeneic transplantation persisted in both BALB/c (n = 18) and C57BL/6J recipients (n = 20). After syngeneic transplantation, CS and CCT values increased in both models in the early phase after surgery due to the surgical trauma. Surprisingly, in the syngeneic C57BL/6J model, high CCT values persisted. Furthermore, anterior synechiae developed in C57BL/6 recipients after both syngeneic and allogeneic transplantation, whereas BALB/c recipients showed almost no synechiae - even though C57/BL6J animals tended to have a deeper anterior chamber (281 ± 11 pixels [mean ± SD]) compared with BALB/c animals of the same age (270 ± 9 pixels [mean ± SD]). Immunohistochemistry revealed numerous CD38+/F4/80 + M1 macrophages in grafts of C57BL/6J recipients following both syngeneic and allogeneic transplantation. However, in BALB/c-recipient mice only sparse M1 macrophages were detectable (CD38 + M1 macrophages relative to all F4/80 + cells: 75 vs. 17% [after allogeneic transplantation] and 66 vs. 17% [after syngeneic transplantation]; p < 0.05). Allogeneic corneal transplants are rejected in BALB/c as well as C57BL/6J mice, but tissue alterations with anterior synechiae are more pronounced in C57BL/6J recipients. Following syngeneic transplantation, C57BL/6J-recipient animals show a persistent graft swelling with increased numbers of CD38+/F4/80 + M1 macrophages in grafted tissue, in contrast to the common model using BALB/c-recipient mice. Our data strongly suggest that strain-dependent differences convey different innate immune responses in BALB/c and C57BL/6J strains. Accordingly, in murine keratoplasty experiments, the mouse line of both donor and recipient animals must be carefully considered. C57BL/6J-recipient mice might be particularly suited to study corneal graft rejection in a clinical setting considered "high risk."

Identifiants

pubmed: 32906119
pii: 000509716
doi: 10.1159/000509716
pmc: PMC7879253
doi:

Substances chimiques

Antigens, Differentiation 0
monocyte-macrophage differentiation antigen 0
ADP-ribosyl Cyclase 1 EC 3.2.2.6

Types de publication

Comparative Study Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

49-59

Informations de copyright

© 2020 The Author(s) Published by S. Karger AG, Basel.

Références

J Am Acad Dermatol. 2006 Jan;54(1):1-15; quiz 16-8
pubmed: 16384751
Arch Ophthalmol. 1991 Feb;109(2):244-51
pubmed: 1993036
Oncoimmunology. 2017 Dec 26;7(4):e1409929
pubmed: 29632723
Invest Ophthalmol Vis Sci. 1997 Dec;38(13):2833-43
pubmed: 9418737
Front Immunol. 2018 Jul 10;9:1593
pubmed: 30042766
Transplantation. 2005 Jan 15;79(1):23-31
pubmed: 15714165
Immunology. 2010 Apr;129(4):556-66
pubmed: 20102413
Invest Ophthalmol Vis Sci. 2000 Oct;41(11):3341-7
pubmed: 11006223
Mol Vis. 2016 Oct 17;22:1248-1255
pubmed: 27777504
Cornea. 2018 Jan;37(1):95-101
pubmed: 29023237
Hum Gene Ther. 2018 Apr;29(4):467-479
pubmed: 28990426
Transpl Immunol. 1996 Mar;4(1):53-6
pubmed: 8762011
Invest Ophthalmol Vis Sci. 1995 Jul;36(8):1530-40
pubmed: 7601633
J Exp Med. 2002 Jan 21;195(2):259-68
pubmed: 11805152
Mol Vis. 2007 Apr 27;13:626-34
pubmed: 17515886
Invest Ophthalmol Vis Sci. 2018 Aug 1;59(10):3911-3919
pubmed: 30073362
Exp Eye Res. 2018 Apr;169:141-148
pubmed: 29305888
Eur J Immunol. 2011 Sep;41(9):2472-6
pubmed: 21952799
Transplantation. 2008 Dec 27;86(12):1720-4
pubmed: 19104411
JAMA Ophthalmol. 2016 Feb;134(2):167-73
pubmed: 26633035
Cornea. 2009 Sep;28(8):865-70
pubmed: 19654531
PLoS One. 2018 Apr 4;13(4):e0194855
pubmed: 29617399
Invest Ophthalmol Vis Sci. 2000 Jul;41(8):2239-47
pubmed: 10892868
PLoS One. 2015 Dec 23;10(12):e0145342
pubmed: 26699615
Immunology. 2016 May;148(1):102-13
pubmed: 26840507
Exp Parasitol. 1988 Apr;65(2):258-68
pubmed: 3127233
Nat Rev Immunol. 2008 Dec;8(12):958-69
pubmed: 19029990
Invest Ophthalmol Vis Sci. 2019 Aug 1;60(10):3669-3679
pubmed: 31469894
Trends Immunol. 2003 Nov;24(11):570-4
pubmed: 14596877
Invest Ophthalmol Vis Sci. 2015 Nov;56(12):7250-9
pubmed: 26544793
Am J Trop Med Hyg. 1982 Mar;31(2):230-8
pubmed: 6462064
Ophthalmic Surg. 1990 Nov;21(11):781-5
pubmed: 2270163
Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2264-71
pubmed: 12091426
Biomed Pharmacother. 2019 May;113:108558
pubmed: 30856534
BMC Microbiol. 2018 May 30;18(1):45
pubmed: 29848308
Sci Rep. 2017 Apr 20;7(1):971
pubmed: 28428556
Immunity. 2014 Jul 17;41(1):14-20
pubmed: 25035950
Cornea. 2019 Jun;38(6):742-747
pubmed: 30882541
Invest Ophthalmol Vis Sci. 2018 Oct 1;59(12):5277-5284
pubmed: 30383199
J Immunol. 2000 Jun 15;164(12):6166-73
pubmed: 10843666
Invest Ophthalmol Vis Sci. 2019 Nov 1;60(14):4511-4519
pubmed: 31675422
Am J Transplant. 2013 Jun;13(6):1461-73
pubmed: 23679575
Biochem Biophys Res Commun. 2018 Jan 15;495(3):2338-2343
pubmed: 29274779
BMC Ophthalmol. 2015 Jul 29;15:87
pubmed: 26219961
Graefes Arch Clin Exp Ophthalmol. 1985;222(3):128-33
pubmed: 3884454
Front Immunol. 2018 Oct 01;9:2246
pubmed: 30327653
Arch Ophthalmol. 2006 Jan;124(1):62-9
pubmed: 16401786

Auteurs

Tim Bleul (T)

Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Xinyu Zhuang (X)

Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Antonia Hildebrand (A)

Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Clemens Lange (C)

Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Daniel Böhringer (D)

Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Günther Schlunck (G)

Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Thomas Reinhard (T)

Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany.

Thabo Lapp (T)

Eye Center, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg im Breisgau, Germany, thabo.lapp@uniklinik-freiburg.de.

Articles similaires

Robotic Surgical Procedures Animals Humans Telemedicine Models, Animal

Odour generalisation and detection dog training.

Lyn Caldicott, Thomas W Pike, Helen E Zulch et al.
1.00
Animals Odorants Dogs Generalization, Psychological Smell
Animals TOR Serine-Threonine Kinases Colorectal Neoplasms Colitis Mice
Animals Tail Swine Behavior, Animal Animal Husbandry

Classifications MeSH